All News

The treatment was first approved in 2013 for adults as a 1500 mg course of treatment, administered as 2 doses of 750 mg each separated by at least 7 days.

Jacob D. Soumerai, MD, of Harvard Medical School and Massachusetts General Hospital, discusses minimum residual disease-driven time limited therapy with zanubrutinib, obinutuzumab, and venetoclax in previously untreated chronic lymphocytic leukemia.

Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity, addresses disparities occurring in diabetes care among racial and ethnic populations.

Sarah Temkin, MD, associate director for clinical research in the Office of Research on Women’s Health (ORWH) at the National Institutes of Health (NIH), discusses the scope and focus of the work of NIH ORWH.

A panel of experts discuss the future of psychedelic medicine and the role of the pharmacy in that future.

The new analysis includes approximately 1100 women without type 1 or type 2 diabetes (T2D) who subsequently gave birth at least once during the 25-year study period, which ended in 2011.

Cutaquig was recently approved for the treatment of pediatric patients aged 2 years and older with primary humoral immunodeficiency.

Study may help guide COVID-19 vaccination strategies for patients with blood disorders.

Researchers to explore possible approaches for designing small molecule therapeutics to combat depression.

Fetal alcohol syndrome causes brain damage and growth problems.

Study shows moderately reduced efficacy of the Moderna COVID-19 vaccine over time against Delta infection, which supports current booster dose recommendations.

Major metabolites for cannabinoids may interfere with two families of enzymes that help metabolize a wide range of drugs prescribed for a variety of conditions.

Health service planning involves a myriad of stakeholders to ensure their sustainability and their integration into other aspects of community health.

Trial seeks to provide high-level evidence for improving the initial treatment for acute Kawasaki disease.

A single booster dose of the GlaxoSmithKline and Sanofi recombinant adjuvanted COVID-19 vaccine candidate delivered consistent and strong immune responses.

Up to 60% of arteriovenous fistulas fail to develop properly due to smooth muscle cell hyperplasia.

Neosporin prevents/treats only bacterial skin infections.

Dabigatran and its acyl glucuronides are competitive, direct thrombin inhibitors.

The "Melt the Phones" campaign is just one of the most recent ways that independent pharmacies and other organizations are working toward DIR reform.

After the initial infection, herpes virus lies dormant in the body and can reactivate several times a year.

The safety profile observed in patients with active psoriatic arthritis administered upadacitinib was consistent with the safety profile observed in patients with rheumatoid arthritis.

The unique challenges that pharmacy learners encountered during the COVID-19 pandemic reinforce their importance in the professional pharmacy setting.

This trial is the first to assess the use of isatuximab as a first-line treatment for newly diagnosed, transplant-eligible patients up to 70 years of age, according to the study authors.

Pharmacists can help to reduce the prevalence of food insecurity and its negative health care outcomes by tailoring clinical care to each individual patient’s needs.

At week 16, 56.4% of patients receiving tofacitinib achieved an Assessment in SpondyloArthritis International Society 20 response.

Patients with hormone receptor-positive breast cancer doubled their median progression-free survival following a switch to fulvestrant plus palbociclib.

Patients with breast cancer treated with pyrotinib plus capecitabine had a 31% lower risk of death than those treated with lapatinib and capecitabine

New technology provides information on the benefit of adding atezolizumab to chemotherapy as a neoadjuvant treatment for patients with early high-risk and locally advanced triple-negative breast cancer.

18th-century German Swedish chemist Carl Wilhelm Scheele’s biggest claims to fame are chlorine, manganese, and oxygen.

Zofran aids in the prevention of nausea and vomiting.